title: [Yellow nail syndrome associated with rheumatoid arthritis. Regression under chrysotherapy].
authors.forename: D
authors.initials: D
authors.lastname: Launay
authors.forename: M
authors.initials: M
authors.lastname: Hebbar
authors.forename: J
authors.initials: J
authors.lastname: Louyot
authors.forename: E
authors.initials: E
authors.lastname: Hachulla
authors.forename: P Y
authors.initials: PY
authors.lastname: Hatron
authors.forename: B
authors.initials: B
authors.lastname: Devulder
mesh_terms: D000368:Aged; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D008297:Male; D009260:Nail Diseases / Q000188:drug therapy / Q000209:etiology*; D050607:Organogold Compounds
chemical_list: D018501:Antirheumatic Agents; D050607:Organogold Compounds
vernacular_title: Syndrome des ongles jaunes associé a une polyarthrite rhumatoïde. Régression sous chrysothérapie.